Sunday, May 5, 2019


A rethink of 10-2 visual fields in early glaucoma



Conventionally, the utilization of visual field programs for analysis of the central retina, such as the 10-2 test, has been confined to patients with advanced glaucoma.  However, over the recent past, a number of studies have shown that Humphrey visual field programs for testing the retinal periphery, such as the 30-2 or 24-2, often miss central defects. A subgroup of patients has been identified which present with central visual field defects during the early course of the disease while retaining normal peripheral visual fields. The diagnosis in these patients will be missed on 24-2 or 30-2 programs unless tested on strategies focused on the central retina. This is leading to a new awareness regarding performing of 10-2 tests early during the disease process. 

To address the issue of the current role of this test in our clinical practice and whether a rethink is required regarding the application of the 10-2 test in early stages of glaucoma a review was undertaken. This review has recently been published by the US Ophthalmic Review journal.

Kindly take a look if it interests you,

With best wishes

Shoeb
The article is available at the following link: 
https://www.touchophthalmology.com/2019/04/29/a-rethink-of-10-2-visual-fields-in-early-glaucoma/


No comments:

Post a Comment

LIGHT-ACTIVATED LIPOSOMES FOR GLAUCOMA

  Biomedical researchers at Binghamton University in the USA, have developed a mechanism for drug-carrying liposomes that can be activated i...